Stock Research for NKTR

NKTR

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

NKTR Stock Chart & Research Data

The NKTR chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the NKTR chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


NKTR Due diligence Resources & Stock Charts

The NKTR stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View NKTR Detailed Price Forecast - CNN Money CNN View NKTR Detailed Summary - Google Finance
Yahoo View NKTR Detailed Summary - Yahoo! Finance Zacks View NKTR Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View NKTR Trends & Analysis - Trade-Ideas Barrons View NKTR Major Holders - Barrons
NASDAQ View NKTR Call Transcripts - NASDAQ Seeking View NKTR Breaking News & Analysis - Seeking Alpha
Spotlight View NKTR Annual Report - CompanySpotlight.com OTC Report View NKTR OTC Short Report - OTCShortReport.com
TradeKing View NKTR Fundamentals - TradeKing Charts View NKTR SEC Filings - Bar Chart
WSJ View Historical Prices for NKTR - The WSJ Morningstar View Performance/Total Return for NKTR - Morningstar
MarketWatch View the Analyst Estimates for NKTR - MarketWatch CNBC View the Earnings History for NKTR - CNBC
StockMarketWatch View the NKTR Earnings - StockMarketWatch MacroAxis View NKTR Buy or Sell Recommendations - MacroAxis
Bullish View the NKTR Bullish Patterns - American Bulls Short Pains View NKTR Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View NKTR Stock Mentions - StockTwits PennyStocks View NKTR Stock Mentions - PennyStockTweets
Twitter View NKTR Stock Mentions - Twitter Invest Hub View NKTR Investment Forum News - Investor Hub
Yahoo View NKTR Stock Mentions - Yahoo! Message Board Seeking Alpha View NKTR Stock Mentions - Seeking Alpha






Financial & Transaction Holdings

SECform4 View Insider Transactions for NKTR - SECform4.com Insider Cow View Insider Transactions for NKTR - Insider Cow
CNBC View NKTR Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for NKTR - OTC Markets
Yahoo View Insider Transactions for NKTR - Yahoo! Finance NASDAQ View Institutional Holdings for NKTR - NASDAQ


Stock Charts

FinViz View NKTR Stock Insight & Charts - FinViz.com StockCharts View NKTR Investment Charts - StockCharts.com
BarChart View NKTR Stock Overview & Charts - BarChart Trading View View NKTR User Generated Charts - Trading View


Latest Financial News for NKTR

Is Nektar Therapeutics Still a Good Bet Despite the Correction?
Posted on Thursday June 21, 2018

Nektar Therapeutics (NASDAQ: NKTR) is a clinical-stage biotech research company that develops drugs for cancer, auto-immune diseases, and chronic pain using its PEGylation and polymer conjugate technology platforms. Earlier in Feb 2018, Nektar secured a deal with Bristol-Myers Squibb (NASDAQ: BMY) to co-develop NKTR-214, where BMY has agreed to pay $1.85 billion in a cash plus stock deal as payment to Nektar, as a result of which Nektar has not failed to leave investors’ radar. Here we use TipRanks data to take a closer look at what Wall Street’s top analysts see in store for this volatile stock.


Nektar Is the One S&P 500 Company Without a Woman Director
Posted on Tuesday June 19, 2018

is the only S&P 500 company without a woman on its board, representing a small improvement in gender diversity from last year. According to a May 31 dataset compiled by BoardEx, a relationship mapping service of TheStreet Inc., San Francisco-based Nektar has no female directors on its board. Meanwhile, eight S&P 500 companies have reached gender parity or greater in the boardroom, including Alliant Energy Corp.


Today's Research Reports on Trending Tickers: Verastem and Nektar Therapeutics
Posted on Monday June 18, 2018

NEW YORK, NY / ACCESSWIRE / June 18, 2018 / U.S. market plunged on Friday, but well-off session lows as investors appeared to look at previous signs of escalating trade tension between Washington and Beijing. ...


Nektar Therapeutics Closed Higher on June 14
Posted on Friday June 15, 2018

The S&P 500’s top gainers on June 14 were: Nektar Therapeutics (NKTR) gained 5.5%. Royal Caribbean Cruises (RCL) gained 5.1%. Comcast Corp A (CMCSA) gained 4.6%. Discovery Comm A (DISCA) gained 4.5%. Incyte (INCY) gained 4.4%. Nektar Therapeutics 


Enter a stock symbol to view the stock details.